Supriya Lifescience

Supriya Lifescience

671.55
-12.30
(-1.80%)
Market Cap
5,404.82 Cr
EPS
23.35
PE Ratio
29.27
Dividend Yield
0.15 %
Industry
Healthcare
52 Week High
842.00
52 Week Low
384.10
PB Ratio
5.52
Debt to Equity
0.02
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,702.20
#1 4,08,414.80
35.57
#1 54,729.00
12.06
#1 10,980
-18.99
55.97
6,584.00
1,74,784.51
80.22
9,712.00
0.89
2,191
23.05
40.37
1,572.00
1,26,971.67
22.93
28,409.50
7.12
5,291
9.88
70.77
3,622.90
1,21,969.00
63.65
11,539.40
6.99
1,911
19.91
72.46
1,287.40
1,07,442.68
#1 18.77
33,741.20
16.73
5,725
1.26
54.50
2,541.60
1,04,899.14
61.83
12,744.20
19.57
2,007
-10.91
52.39
980.10
98,620.99
21.15
23,511.00
13.82
4,615
-0.19
54.96
1,960.50
89,535.15
27.44
22,909.50
#1 19.94
3,306
#1 112.49
53.75
32,895.00
69,899.58
50.72
6,684.70
10.80
1,414
27.83
42.22
1,127.00
65,456.34
18.86
31,378.10
17.55
3,366
-0.50
47.15
Forecast
Actual
Growth Rate
Revenue Growth
23.51 %
Net Income Growth
32.48 %
Cash Flow Change
78.13 %
ROE
13.70 %
ROCE
13.74 %
EBITDA Margin (Avg.)
7.41 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
140
172
191
222
286
323
396
538
470
581
696
Expenses
121
150
166
191
213
213
218
316
332
397
436
EBITDA
20
22
25
31
73
110
178
222
138
184
261
Operating Profit %
12 %
12 %
9 %
10 %
23 %
32 %
44 %
40 %
28 %
30 %
37 %
Depreciation
3
4
5
5
5
6
7
10
12
16
20
Interest
7
10
12
11
10
7
4
4
3
2
2
Profit Before Tax
10
8
8
15
57
96
167
207
124
166
248
Tax
2
2
2
6
18
23
44
55
34
47
57
Net Profit
8
6
6
9
39
73
124
152
90
119
192
EPS in ₹
16.82
3.89
3.87
1.19
5.39
10.02
16.89
18.86
11.16
14.80
23.35

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
176
231
241
245
253
336
446
735
820
921
1,112
Fixed Assets
61
76
89
91
85
99
100
190
262
310
601
Current Assets
103
129
115
120
133
196
266
498
465
398
437
Capital Work in Progress
11
25
36
34
35
40
79
43
68
149
148
Investments
0
0
0
0
0
0
0
0
25
64
118
Other Assets
104
131
117
120
133
197
267
502
466
399
0
Total Liabilities
176
231
241
245
253
336
446
735
820
921
1,112
Current Liabilities
115
150
144
146
135
155
146
100
96
77
82
Non Current Liabilities
23
39
51
45
24
32
31
19
25
29
33
Total Equity
37
42
46
55
94
149
269
616
700
815
997
Reserve & Surplus
33
26
31
40
79
134
254
600
683
799
981
Share Capital
5
15
15
15
15
15
15
16
16
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
2
-2
3
4
62
15
139
-70
-83
Investing Activities
-23
-33
-27
-5
5
-25
-47
-60
-124
-174
Operating Activities
-6
14
27
28
49
117
76
49
64
113
Financing Activities
30
21
-2
-20
-50
-29
-15
150
-10
-22

Share Holding

% Holding
May 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
99.98 %
68.24 %
68.24 %
68.24 %
68.24 %
68.24 %
68.28 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.34 %
0.00 %
5.36 %
4.95 %
6.03 %
6.52 %
7.19 %
6.78 %
DIIs
0.00 %
5.20 %
4.72 %
7.27 %
6.23 %
7.89 %
7.65 %
7.55 %
7.17 %
3.85 %
5.30 %
5.48 %
5.45 %
4.92 %
4.26 %
4.86 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
8.25 %
12.73 %
12.52 %
13.40 %
15.07 %
15.54 %
15.39 %
16.10 %
17.50 %
17.06 %
17.19 %
0.00 %
16.28 %
16.40 %
16.39 %
Others
0.02 %
18.30 %
14.31 %
11.97 %
12.13 %
8.80 %
8.53 %
8.76 %
3.09 %
10.35 %
3.98 %
4.08 %
20.23 %
3.98 %
3.85 %
3.67 %
No of Share Holders
7
50,506
82,578
86,853
94,594
96,998
95,605
93,478
92,991
95,929
87,980
89,621
85,328
89,394
91,051
91,928

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.54 0.6 0.6 0.8 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.11 0.32 0.18 0.11 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 701.60 742.45
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 669.40 730.35
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 555.10 547.30
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 627.75 588.85
21 Sept 2024 DIVIDEND Dividend
₹ 0.80 /share
20 Sept 2024 360.75 630.75
15 Sept 2023 DIVIDEND Dividend
₹ 0.60 /share
15 Sept 2023 257.55 292.40
02 Sept 2022 DIVIDEND Dividend
₹ 0.60 /share
01 Sept 2022 355.25 355.05

Announcements

Clarification Regarding Shareholder Demat Requests5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 01, 2025
Closure of Trading WindowJun 27, 2025
Email Communication To Shareholders Regarding Dividend Taxation ProvisionsJun 17, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 31, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 27, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 27, 2025
Appointment Of Secretarial Auditor For Term Of Five (5) Consecutive YearsMay 27, 2025
Corporate Action-Board to consider DividendMay 27, 2025
Audited Financial Result For Quarter And Year Ended On March 31 2025May 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On May 27 2025May 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2025 And Recommend Dividend If Any On The Equity Shares Of The Company For The Financial Year Ended March 31 2025May 20, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 01, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2025
Details Of Key Managerial Personnel Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 10, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 10, 2025
Appointment of Company Secretary and Compliance OfficerMar 10, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held To Consider Appointment Of Company Secretary And Compliance Officer Of The Company.Mar 10, 2025
Board Meeting Intimation for Appointment Of Company Secretary And Compliance Officer Of The CompanyMar 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 01, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 27, 2025
Audio Recording Of Earnings CallJan 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Jan 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 25, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 24, 2025
Integrated Filing (Financial)Jan 24, 2025

Technical Indicators

RSI(14)
Neutral
39.76
ATR(14)
Volatile
22.54
STOCH(9,6)
Oversold
16.62
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-4.26
ADX(14)
Weak Trend
17.21
UO(9)
Bearish
30.34
ROC(12)
Downtrend And Accelerating
-5.31
WillR(14)
Oversold
-93.89